Posted on 05/06/2020
The team is pleased to be investigators on 2 new MRFF funded grants, both led by Prof. Tony Keech, to try and reduce cardiovascular disease.
The CASPER trial will determine if colchicine after stroke can prevent another stroke.
The IMPACTICO study will test if colchicine and immune-modulatory particles can improve outcomes for people hospitalised with COVID19.
More information here: https://www.sydney.edu.au/news-opinion/news/2020/06/05/heart-disease-stroke-research-receives-12-4-million-federal-fund.html?tc=tw-o%7Cmpr-twitter%7Cmc-media%7C%7C%7C